Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced the completion of patient enrollment in REVITALYZ, a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback